Related Experiment Videos

Abnormal splenic megakaryopoiesis in MPSV-induced myeloproliferative disease

M C Le Bousse-Kerdiles1, R Fernandez-Delgado, F Smadja-Joffe

  • 1INSERM U 268, Hôpital Paul Brousse, Villejuif, France.

Leukemia Research
|January 1, 1987
PubMed

Insights

Myeloproliferative sarcoma virus (MPSV) causes spleen fibrosis and increased megakaryocyte precursors in mice. Thrombocytopenia results from precursor destruction, not deficiency, making this a model for myeloproliferative syndromes.

Area of Science:

  • Hematology
  • Oncology
  • Virology

Background:

  • Myeloproliferative sarcoma virus (MPSV) induces a murine myeloproliferative syndrome.
  • This syndrome is characterized by erythremic myelosis, anemia, thrombocytopenia, splenomegaly, and fibrosis.

Purpose of the Study:

  • To investigate megakaryocytic precursor levels in MPSV-infected mice.
  • To determine the cause of thrombocytopenia in this model.

Main Methods:

  • Utilized the in-vitro plasma clot technique.
  • Quantified megakaryocytic colony-forming units in spleen and bone marrow of MPSV-infected mice.

Main Results:

  • Megakaryocytic colonies significantly increased in number, concentration, and size within the spleen, but not bone marrow.
  • Splenic megakaryocyte precursors exhibited hypersensitivity to growth factors in anemic mouse serum.
  • Thrombocytopenia was attributed to excessive megakaryocyte destruction rather than precursor deficiency.

Conclusions:

  • The MPSV-induced murine model displays ineffective splenic megakaryopoiesis and significant splenic fibrosis.
  • This model is suitable for studying megakaryopoiesis perturbations in myeloproliferative neoplasms associated with fibrosis.

Related Concept Videos